AtonRa Partners
- SEC CIK
- 0001846445
- Latest filing
- Feb 5, 2024
ITCI holding history
Intra-Cellular Therapies, Inc. in every 13F filed by AtonRa Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ITCI overviewAll 13F holders of ITCIFull Q4 2023 holdings
- Shares (Q4 2023)
- 5,772
- Value
- $413.4K
- % of portfolio
- 0.8%
- Quarters held
- 7
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 5,772 | $413.4K | 0.8% | −566−8.9% | Reduced | Holders |
| Q3 2023 | 6,338 | $330.1K | 0.7% | −1,485−19.0% | Reduced | Holders |
| Q2 2023 | 7,823 | $495.4K | 0.8% | −724−8.5% | Reduced | Holders |
| Q1 2023 | 8,547 | $462.8K | 0.7% | −948−10.0% | Reduced | Holders |
| Q4 2022 | 9,495 | $502.5K | 0.6% | −2,568−21.3% | Reduced | Holders |
| Q3 2022 | 12,063 | $561.0K | 0.6% | −158−1.3% | Reduced | Holders |
| Q2 2022 | 12,221 | $698.0K | 0.6% | +12,221 | New | Holders |